Arbidol synthesis is a multi-step process that demands precise control at each stage. As a key antiviral API, Arbidol requires high-purity intermediates to achieve the ≥98% overall purity standard required for pharmaceutical use. The synthetic route to Arbidol typically begins with inexpensive ethyl acetoacetate as the starting material and proceeds through Nenitzescu reaction, acylation, bromination, thiophenolisation, Mannich reaction, and salt formation. Each Arbidol intermediate in our portfolio is characterized with HPLC purity verification, NMR identity confirmation, and residual solvent analysis to ensure seamless progression through the synthetic cascade. Cosperpharm's Arbidol intermediates are designed to support both laboratory-scale R&D and commercial manufacturing campaigns.
Products
|
Intermediate 1 CAS |
870-85-9 |
|
Intermediate 2 CAS |
15574-49-9 |
|
Intermediate 3 CAS |
40945-79-7 |
|
Intermediate 4 CAS |
110543-98-1 |
|
Intermediate 5 CAS |
131707-24-9 |
|
Intermediate 6 CAS |
131707-25-0 |
Contact Us
Looking for high-quality Arbidol intermediates for your antiviral API manufacturing or indole-based drug development program? Cosperpharm delivers the purity, documentation, and supply flexibility you need. Contact our team today—we're ready to support your project from R&D to commercial production.
No. 2 Yangguang 3rd Road, Duodao Chemical Cycle Industrial Park, Jingmen City, Hubei Province, China
Copyright © 2026 Cosper Pharma Tech Co., Ltd. All Rights Reserved.